COVID-19 presenting as a viral exanthem and detected during admission prescreening in a hematopoietic cell transplant recipient

Authors: Ahmed, Nausheen, Lima, Marcos de, Rohr, Bethany R., Tomlinson, Benjamin K.

Source: Hematology, Transfusion and Cell Therapy. September 2020 42(3)

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000300215

A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia

Authors: Tomlinson, Benjamin K., Gallogly, Molly M., Kane, Donna M., Metheny, Leland, Lazarus, Hillard M., William, Basem M., Craig, Michael D., Levis, Mark J., Cooper, Brenda W.

Source: In Clinical Lymphoma, Myeloma and Leukemia April 2020 20(4):226-233

Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia

Authors: Covut, Fahrettin, Gupta, Divya, Pinto, Raisa, Dambrosio, Nina, El Jurdi, Najla, Meyerson, Howard, Ueda, Masumi, Kolk, Merle, Creger, Richard, Metheny, Leland, Cooper, Brenda W., Caimi, Paolo F., Malek, Ehsan, Otegbeye, Folashade, Lazarus, Hillard M., De Lima, Marcos, Tomlinson, Benjamin K.

Source: In Clinical Lymphoma, Myeloma and Leukemia February 2019 19(2):73-82

Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation

Authors: Ali, Naveed, Sharma, Ashish Arunkumar, de Rezende, Ana Carolina Pires, Otegbeye, Folashade, Latif, Bilal Muhammad, Kerbauy, Mariana Nassif, Cooper, Brenda W., Sanchez, Gabriela, Metheny, Leland, Bal, Saswat K., Sakuraba, Roberto, Tomlinson, Benjamin K., Boughan, Kirsten M., Kerbauy, Lucila, Malek, Ehsan, Ribeiro, Andreza Feitosa, Gallogly, Molly, Mansur, David, Pereira, Gisele, Weltman, Eduardo, Sekaly, Rafick-Pierre, de Lima, Marcos, Caimi, Paolo F., Hamerschlak, Nelson

Source: In Transplantation and Cellular Therapy July 2022 28(7):370-370

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Authors: Garcia, Jacqueline S., Flamand, Yael, Penter, Livius, Keng, Michael, Tomlinson, Benjamin K., Mendez, Lourdes M., Koller, Paul, Cullen, Nicole, Arihara, Yohei, Pfaff, Kathleen, Wolff, Jacquelyn O., Brunner, Andrew M., Galinsky, Ilene, Bashey, Asad, Antin, Joseph H., Cutler, Corey, Ho, Vincent, Jonas, Brian A., Luskin, Marlise R., Wadleigh, Martha, Winer, Eric S., Savell, Alexandra, Leonard, Rebecca, Robertson, Taylor, Davids, Matthew S., Streicher, Howard, Rodig, Scott J., Ritz, Jerome, Wu, Catherine J., DeAngelo, Daniel J., Neuberg, Donna, Stone, Richard M., Soiffer, Robert J.

Source: In Blood 13 April 2023 141(15):1884-1888

Development of a Machine Learning Algorithm for Rapid, Point-of-Care Prediction of Serum Monoclonal Proteins in Multiple Myeloma

Authors: Malek, Ehsan, Kort, Jeries, Wang, Gi-Ming ^*, Caimi, Paolo F, Boughan, Kirsten M, Gerson, Stanton L., Cooper, Brenda W., Gallogly, Molly M, Tomlinson, Benjamin K., de Lima, Marcos, Tatsuoka, Curtis ^*, Driscoll, James ^*

Source: In Blood 5 November 2020 136 Supplement 1:13-15

Personalized Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia Results in Successful Donor Hematopoietic Cells Engraftment with the Timing of Engraftment Not Related to the Radiation Dose Delivered

Authors: Gyurkocza, Boglarka, Nath, Rajneesh, Choe, Hannah, Seropian, Stuart, Stiff, Patrick J., Abhyankar, Sunil, Agura, Edward, Litzow, Mark, Tomlinson, Benjamin K., Chen, George L., Hari, Parameswaran, Orozco, Johnnie ^*, Al-Kadhimi, Zaid S. ^*, Abboud, Camille, Van Besien, Koen, Sabloff, Mitchell, Magalhaes-Silverman, Margarida Magalhaes, Foran, James M., Schuster, Michael W., Kebriaei, Partow, Levy, Moshe Y., Lazarus, Hillard M, Giralt, Sergio A., Liang, Qing ^*, Berger, Mark S., Reddy, Vijay, Pagel, John M.

Source: In Blood 5 November 2020 136 Supplement 1:42-44

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Authors: Garcia, Jacqueline S., Flamand, Yael ^*, Tomlinson, Benjamin K., Keng, Michael ^*, Mendez, Lourdes M., Khaled, Samer, Bashey, Asad, Brunner, Andrew M., Savell, Alexandra ^*, Neuberg, Donna ^*, Galinsky, Ilene ^*, Luskin, Marlise R., Steensma, David P., Wadleigh, Martha ^*, Winer, Eric S., Avigan, David E., Cullen, Nicole ^*, Rodig, Scott, Penter, Livius ^*, Lindsley, R. Coleman, Andrews, Stephanie ^*, Davids, Matthew S., Wu, Catherine J., Stone, Richard M., DeAngelo, Daniel J., Soiffer, Robert J.

Source: In Blood 5 November 2020 136 Supplement 1:15-17

A Phase I Clinical Trial of Fully Human Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Authors: Cooper, Brenda W, Gallogly, Molly Megan, Metheny, Leland, Klisovic, Rebecca B., Boughan, Kirsten Marie, Reese Koc, Jane, Wu, Darong, Deng, Changchun, Van Besien, Koen, Tupta, Rose, Schneider, Dina, Ciarrone, Lisa, de Lima, Marcos, Caimi, Paolo F., Tomlinson, Benjamin K.

Source: In Blood 2 November 2023 142 Supplement 1:6872-6872

Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemia.

Authors: Wang, Jiasheng, de Lima, Marcos, Cooper, Brenda W., Boughan, Kirsten, Metheny, Leland, Otegbeye, Folashade, Caimi, Paolo F., Gallogly, Molly, Malek, Ehsan, Cao, Shufen, Fu, Pingfu, Glotzbecker, Brett, Schiltz, Nicholas K., Tomlinson, Benjamin K.

Source: Leukemia & Lymphoma; Jun2021, Vol. 62 Issue 6, p1450-1457, 8p

Subject Terms: ACUTE myeloid leukemia, FILGRASTIM, BONE marrow, OVERALL survival, PROGRESSION-free survival

A Phase 1 Study of Sea-CD70 in Myeloid Malignancies

Authors: Aribi, Ahmed ^*, Advani, Anjali S, Donnellan, William, Fathi, Amir T., Rotta, Marcello, Tomlinson, Benjamin K., Vachani, Pankit ^*, Yang, Jay, Ho, Phoenix, Garcia-Manero, Guillermo

Source: In Blood 5 November 2020 136 Supplement 1:23-24

Venetoclax Inhibition of Pyrimidine Synthesis Guides Methods for Integration with Decitabine or 5-Azacytidine That Are Non-Myelosuppressive

Authors: Gu, Xiaorong ^*, Tohme, Rita ^*, Goldfinger, Mendel ^*, Tomlinson, Benjamin K., Sakre, Nneha ^*, Hanmer, Shannon ^*, Jha, Babal K. ^*, Maciejewski, Jaroslaw P., Verma, Amit, Saunthararajah, Yogenthiran

Source: In Blood 5 November 2020 136 Supplement 1:26-27

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Authors: Ali, Naveed, de Rezende, Ana Carolina Pires ^*, Otegbeye, Folashade, Kerbauy, Mariana Nassif ^*, Cooper, Brenda W., Mansur, David ^*, Pereira, Gisele ^*, Sakuraba, Roberto ^*, Tomlinson, Benjamin K., Boughan, Kirsten M, Silva, Cinthya Correa ^*, Metheny, Leland, III, Ribeiro, Andreza Feitosa, Gallogly, Molly M, Malek, Ehsan, Weltman, EDuardo ^*, de Lima, Marcos, Hamerschlak, Nelson, Caimi, Paolo F

Source: In Blood 5 November 2020 136 Supplement 1:29-30

Patient Selection Bias Limits the Real World Efficacy of Randomized Clinical Trials in Multiple Myeloma

Authors: Eduafo, Augusta ^*, Metheny, Leland, III, Driscoll, James ^*, Tomlinson, Benjamin K., Boughan, Kirsten M, Gallogly, Molly M, de Lima, Marcos, Malek, Ehsan

Source: In Blood 5 November 2020 136 Supplement 1:1-2

High Doses of Targeted Radiation with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Do Not Correlate with Incidence of Mucositis, Febrile Neutropenia or Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Authors: Gyurkocza, Boglarka, Nath, Rajneesh, Choe, Hannah, Seropian, Stuart, Stiff, Patrick J., Abhyankar, Sunil, Agura, Edward, Litzow, Mark, Tomlinson, Benjamin K., Chen, George L., Hari, Parameswaran, Orozco, Johnnie ^*, Al-Kadhimi, Zaid S. ^*, Abboud, Camille, Van Besien, Koen, Sabloff, Mitchell, Magalhaes-Silverman, Margarida Magalhaes, Foran, James M., Schuster, Michael W., Kebriaei, Partow, Levy, Moshe ^*, Lazarus, Hillard M, Giralt, Sergio A., Liang, Qing ^*, Berger, Mark S., Reddy, Vijay, Pagel, John M.

Source: In Blood 5 November 2020 136 Supplement 1:30-31

ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings.

Authors: Kassem, Alaa M., Keinath, Melissa C., Adler, Jason A., Gadde, Ramya, Tomlinson, Benjamin K., Shetty, Shashirekha

Source: British Journal of Haematology; Sep2023, Vol. 202 Issue 6, p1077-1078, 2p

Subject Terms: ACUTE promyelocytic leukemia, PATHOLOGY, BLOOD cell count, CEREBRAL hemorrhage

A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia.

Authors: Tomlinson, Benjamin K., Tuscano, Joseph M., Abedi, Mehrdad, Welborn, Jeanna, Arora, Mili, O'Donnell, Robert T., Wun, Ted, Jonas, Brian A.

Source: American Journal of Hematology; Nov2019, Vol. 94 Issue 11, pE291-E294, 4p

Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction

Authors: Cao, Shufen ^*, Dharmavaram, Gouri ^*, Boughan, Kirsten M, Cooper, Brenda, Gallogly, Molly M, Malek, Ehsan, Metheny, Leland, III, Otegbeye, Folashade, Tomlinson, Benjamin K., de Lima, Marcos, Fu, Pingfu ^*, Caimi, Paolo F

Source: In Blood 13 November 2019 134 Supplement 1:4770-4770

Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas

Authors: Caimi, Paolo F, Reese, Jane ^*, Otegbeye, Folashade, Schneider, Dina ^*, Bakalarz, Kristen ^*, Boughan, Kirsten M, Cooper, Brenda, Gallogly, Molly M, Galloway, Erin ^*, Kruger, Winfried ^*, Worden, Andrew ^*, Kadan, Michael ^*, Lopes, Filipa Blasco ^*, Sharma, Ashish ^*, Malek, Ehsan, Metheny, Leland, III, Patel, Seema ^*, Tomlinson, Benjamin K., Wald, David ^*, Sekaly, Rafick-Pierre ^*, Orentas, Rimas ^*, Dropulic, Boro ^*, de Lima, Marcos

Source: In Blood 13 November 2019 134 Supplement 1:4074-4074

Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor

Authors: Grunwald, Michael R., Zhang, Mei-Jie ^*, Elmariah, Hany, Johnson, Mariam H ^*, St. Martin, Andrew ^*, Bashey, Asad, Bolanos-Meade, Javier, Bredeson, Christopher, Copelan, Edward A, George, Biju, Gupta, Vikas, Kanakry, Christopher G. ^*, Mehta, Rohtesh S., Battiwalla, Minoo, Mussetti, Alberto ^*, Nakamura, Ryotaro, Nishihori, Taiga, Saber, Wael, Solh, Melhem, Tomlinson, Benjamin K., Weisdorf, Daniel J., Eapen, Mary

Source: In Blood 13 November 2019 134 Supplement 1:3323-3323